Literature DB >> 27792695

[Gender differences in lipocalin 2 plasmatic levels are correlated with age and the triglyceride/high-density lipoprotein ratio in healthy individuals].

Elsa De la Chesnaye1, Leticia Manuel-Apolinar2, Norma Oviedo-de Anda1, María Cristina Revilla-Monsalve1, Sergio Islas-Andrade1.   

Abstract

INTRODUCTION: The increment of lipocalin 2, also called neutrophil gelatinase-associated lipocalin, plasmatic levels is associated with cardiometabolic and nefrologic alterations. Nonetheless, there is much controversy about lipocalin 2 plasmatic concentrations among healthy individuals. AIM: The aim of this study was to quantify lipocalin 2 in plasma of healthy men and women and to assess a possible correlation with cardiometabolic risk factors.
METHODS: Fifty-three subjects (24 men and 29 women) were included. By means of an ELISA, a higher concentration of lipocalin 2 was observed in men than in women (91 ± 9 vs. 57 ± 7 ng/ml). Such difference was statistically significant (p < 0.0001).
RESULTS: Lipocalin 2 levels were significantly correlated with body mass index, homeostasis model assessment index-insulin resistance index, triglycerides, high-density lipoprotein, and age.
CONCLUSION: Lipocalin 2 plasmatic concentrations present a gender-specific profile in healthy subjects and its circulating levels appear to be age-dependent and associated with several cardiometabolic risk factors, including the triglycerides/high-density lipoprotein cholesterol ratio, which has proven to be a reliable marker for cardiometabolic risk among the global population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27792695

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  5 in total

1.  Sex-specific metabolic functions of adipose Lipocalin-2.

Authors:  Karthickeyan Chella Krishnan; Simon Sabir; Michaël Shum; Yonghong Meng; Rebeca Acín-Pérez; Jennifer M Lang; Raquel R Floyd; Laurent Vergnes; Marcus M Seldin; Brie K Fuqua; Dulshan W Jayasekera; Sereena K Nand; Diana C Anum; Calvin Pan; Linsey Stiles; Miklós Péterfy; Karen Reue; Marc Liesa; Aldons J Lusis
Journal:  Mol Metab       Date:  2019-09-27       Impact factor: 7.422

2.  Lipocalin-2 Variants and Their Relationship With Cardio-Renal Risk Factors.

Authors:  Dahui Li; Haoyun Li; Carlie Bauer; Yue Hu; Joshua R Lewis; Aimin Xu; Itamar Levinger; Yu Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-06       Impact factor: 5.555

3.  Association Of Blood Lipocalin-2 Levels with Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Jing Zhu; Shuai Jiang; Xiaohong Jiang; Kaiming Luo; Xiaolin Huang; Fei Hua
Journal:  Horm Metab Res       Date:  2022-10-07       Impact factor: 2.788

4.  Expression profiling of lipocalin-2 and 24p3 receptor in murine gonads at different developmental stages.

Authors:  Elsa De La Chesnaye; Leticia Manuel-Apolinar; Leticia Damasio; Aleida Olivares; Miguel Angel Palomino; Isis Santos; Juan Pablo Méndez
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

5.  Association Between Iron-Related Protein Lipocalin 2 and Cognitive Impairment in Cerebrospinal Fluid and Serum.

Authors:  Sofia Pereira das Neves; Ricardo Taipa; Fernanda Marques; Patrício Soares Costa; Joel Monárrez-Espino; Joana A Palha; Miia Kivipelto
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.